Home > Journals > Minerva Medica > Past Issues > Minerva Medica 2015 October;106(5) > Minerva Medica 2015 October;106(5):309-13

CURRENT ISSUEMINERVA MEDICA

A Journal on Internal Medicine


Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,236


eTOC

 

CORRESPONDENCE  


Minerva Medica 2015 October;106(5):309-13

language: English

Impact of genetic signature on breast cancer therapy: preliminary experience

Rulli A. 1, 2, Listorti C. 1, 2, Foglietta J. 3, Burattini M. F. 4, Caracappa D. 1, Palumbo I. 5, Barberini F. 1, 2, Covarelli P. 4, Boselli C. 2

1 Breast Unit, Department of Surgical Oncology, University of Perugia, Perugia, Italy;
2 Department of Surgical Oncology, University of Perugia, Perugia, Italy;
3 Department of Medical Oncology, Santa Maria della Misericordia Hospital, Perugia, Italy;
4 Department of Surgical Oncology, University of Perugia, Perugia, Italy;
5 Department of Oncological Radiotherapy, Santa Maria della Misericordia Hospital, Perugia, Italy;


PDF  REPRINTS


top of page